Bench to Bedside

The human papillomavirus (HPV) vaccine has been available since 2006, and physicians at The University of Kansas Cancer Center have encouraged our patients to get the vaccination. The vaccine is FDA-approved for children at age 9 and recommended for preteen boys and girls at age 11 or 12. Men and women between the ages of 27 and 45, who didn't get the vaccination as an adolescent, can also receive...

Nature's bounty holds great promise for the treatment of cancer and has played a vital role in the development of cancer therapies. This challenging yet exciting field of research holds great promise as we look for better ways to preventing the development of cancer.   Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, speaks with Dr. Carol Fabian and Dr. Farib...

Forty percent of adults and 20% of children are obese, and those percentages are rising. By 2030, researchers project that obesity will affect nearly half of US adults. Obesity is associated with a higher risk of 13 types of cancer as well as poorer survival rates for several types of cancer. Dr. Roy Jensen, director of The University of Kansas Cancer Center, speaks with Dr. Christie Befort, assoc...

When a person in need of a blood marrow transplant can't find a perfect match donor, there is still hope. To increase the likelihood of finding every person who needs a transplant a match, diversity in the donor database is critical. Tune in to learn more about alternative donor options and the need for more donor diversity.

At The University of Kansas Cancer Center cancer survivors, co-survivors and researchers work together to design research that may lead to improved treatments and therapies. The program, called Patient and Investigator Voices Organizing Together (PIVOT) is one of the few such cancer center patient research advocacy initiatives in the country. On this episode of Bench to Bedside, hear from breast c...

Triple-negative breast cancer is the rarest and most aggressive type of breast cancer. Tune in to hear from one of the leading researchers studying this type of cancer, Dr. Priyanka Sharma. Also joining us will be Cynthia Newsome, an NBC Action News anchor in Kansas City who is also a triple-negative breast cancer patient.

About 1 in 8 U.S. men will develop prostate cancer in his lifetime. Learn about our multidisciplinary team of prostate cancer experts, who work together to determine the best treatment plan for each patient.

African Americans smoke fewer cigarettes and start smoking cigarettes at an older age that whites, but they are more likely to die from smoking-related diseases. On this episode of Bench to Bedside, Dr. Nikki Nollen, co-leader of The University of Kansas Cancer Center's Cancer Prevention and Control research program, and Tricia Snow, project director of Kick it at Swope, discuss what researchers a...

Ronald Chen, MD, MPH, chair of the Department of Radiation Oncology and associate director for Health Equity at The University of Kansas Cancer Center, and Shalina Gupta-Burt, MD, radiation oncologist at The University of Kansas Health System St. Francis Campus, will talk about the new partnership that will expand access to the most advanced cancer care to patients in Topeka and across northeast K...

Pelvic pain and atrophy is a common side effect to cancer treatment that is often not talked about. Tune in to learn more about the supportive care we offer. If this is a side effect you are experiencing, you are not alone, and you do not have to live with the pain.   Melanie Meister, MD, urogynecologist, talks about pelvic pain and atrophy. Also joining the conversation is Eileen Coughenour, DPT,...

The prognosis for brain cancer has not changed much over the last few decades, but researchers at The University of Kansas Cancer Center are working to change that. Dr. David Akhavan, radiation oncologist and physician-scientist, will share how immunotherapy for brain cancer is the next breakthrough in research. Also joining the conversation will be Matt Anthony, founder of Head for the Cure and a...

To make progress against cancer, we need everyone's help! Dr. Tara Lin, director of The University of Kansas Cancer Center's Clinical Trials Office and Cici Rojas, a cancer survivor who participated in a clinical trial and a leader in Kansas City's Latinx community, are joining Dr. Roy Jensen to talk about why diversity in clinical research is so important.

For many cancer patients and survivors, changes in appearance caused by treatments or surgery pose physical and emotional obstacles to recovery. An accredited cancer appearance center, Missys' Boutique® helps overcome these obstacles with spirit and style. Tune in to learn more about the boutique's mission to help cancer patients and survivors throughout the region restore their dignity, build the...

You may have heard us say, "where you get your mammogram matters." But do you know why? Hear breast radiologist Onalisa Winblad, MD, delve into why "where you get your mammogram" really does matter.

In honor of the 50th anniversary of the National Cancer Act, Dr. Norman Sharpless, director of the National Cancer Institute, and Dr. Henry Ciolino, director of the Office of NCI Cancer Centers, join Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, on a very special episode to discuss all things cancer research.

Study results show CAR T-cell therapy improves survival for adults with large B-cell lymphoma who did not respond well to or relapsed after, the first line of treatment. Learn about CAR T-cell therapy for large B-cell lymphoma from Dr. Joseph McGuirk, medical director of the blood and marrow transplant program at The University of Kansas Cancer Center.

18 months into a global pandemic, half of the United States has been vaccinated against COVID-19, but we are at the height of yet another surge as the highly contagious Delta variant rages. Dr. Wejing Sun, director of Medical Oncology and associate director for clinical research at The University of Kansas Cancer Center, explains how we care for one of our most vulnerable populations, our cancer p...

Accurate information and medical advice are more important than ever for cancer patients. On this week's episode of #BenchToBedside, vaccine expert, Dr. Kevin Ault, shares insight into the COVID-19 vaccine and its implications for cancer patients.  

Dr. Roy Jensen, director of The University of Kansas Cancer Center, talks with Annie Seal, children's program director at Turning Point, and Laura Frees, co-survivor and member of Patient and Investigator Voices Organizing Together (PIVOT), on how to talk to children about a loved one's cancer diagnosis.

Experts discuss the progress we are making toward being able to provide proton therapy for our patients. Proton therapy is the most technologically advanced method to deliver radiation treatment to cancerous tumors available today.